文献速递睡眠呼吸障碍

婴幼儿OSA的正压通气治疗有效性与依从性研究

Positive Airway Pressure for the Treatment of OSA in Infants.
PubMed 文献 · Chest · 2020-08-15

结论提示PAP对婴儿OSA高效且耐受良好,应与其他疗法一同考虑。

要点

  • PAP滴定可显著降低婴儿OSA的OAHI,降幅与学龄儿童相当。
  • 婴儿PAP依从性优于学龄儿童,使用夜数比例更高。
  • 两组依从性障碍均以行为因素最常见,无组间差异。

核心结论

  • PAP治疗婴儿OSA高效且耐受良好,应与其他疗法一同考虑用于最年幼儿童。

研究设计与样本

  • 比较基线及滴定多导睡眠图数据、PAP依从性数据及家长报告的依从障碍。

主要发现

  • 两组依从性障碍无差异,行为障碍在两组均最常见。

临床怎么用

  • 对<6月龄OSA婴儿,PAP可作为有效的治疗选择进行滴定和随访。
  • 婴儿PAP依从性可能优于学龄儿童,但仍需关注行为性依从障碍。

局限性

  • 单中心回顾性设计,样本量有限,结论需更广泛验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Positive airway pressure (PAP) is a standard therapy for the treatment of OSA in children, but objective data on the effectiveness of PAP in infants are sparse. The aim of this study was to compare the effectiveness of PAP in infants younger than 6 months of age with that in school-aged children. RESEARCH QUESTION: Compared with PAP in school-aged children, can PAP be titrated as successfully in infants, and is adherence to PAP similar in both age groups? STUDY DESIGN AND METHODS: Single-center retrospective study. For consecutive infants younger than 6 months of age and school-aged children 5 to 10 years of age with OSA treated with PAP, baseline and titration polysomnography data, PAP adherence data, and parent-reported barriers to adherence were compared between groups. RESULTS: Forty-one infants and 109 school-aged children were included. Median obstructive apnea hypopnea index (OAHI) in infants was 25.7/h (interquartile range [IQR], 17.8-35.9/h) and was greater than that in school-aged children (12.1/hr; IQR, 7.6-21.5/h; P < .0001). After PAP titration, OAHI was reduced by a median of 92.1% in infants, similar to the median 93.4% reduction in school-aged children (P = .67). PAP was used in infants on 94.7% of nights, which was more than the 83% in school-aged children (P = .003). No differences were found in barriers to adherence between infants and school-aged children, with behavioral barriers being most common in both groups. INTERPRETATION: Objective data demonstrate that PAP is both highly effective at treating OSA and well-tolerated in infants. Like older patients, PAP should be considered along with other therapies for the treatment of OSA in even the youngest children.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Cielo CM, Hernandez P, Ciampaglia AM, et al. Positive Airway Pressure for the Treatment of OSA in Infants. Chest. 2020. PMID: 32805239. doi:10.1016/j.chest.2020.08.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。